Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eric Van Cutsem

Showing results (1-10 of 499) with videos related to

Pageof 50
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 20, 2006
Progress with biological agents in metastatic colorectal cancer leads to many challengesEric Van Cutsem
Clinical Advances in Hematology & Oncology : H&O|November 6, 2007
Integration of the anti-EGFR agent panitumumab into clinical practice in metastatic colorectal cancerEric Van Cutsem
Clinical Colorectal Cancer|December 6, 2007
Optimizing administration of epidermal growth factor receptor-targeted agents in the treatment of colorectal cancerEric Van Cutsem
Future Oncology (London, England)|November 26, 2025
Trastuzumab deruxtecan in HER2-positive stomach or gastroesophageal junction cancer: a plain language summary of the DESTINY-Gastric02 studyEric Van Cutsem
The Oncologist|October 13, 2006
Challenges in the use of epidermal growth factor receptor inhibitors in colorectal cancerEric Van Cutsem
The Oncologist|May 27, 2004
The treatment of advanced gastric cancer: new findings on the activity of the taxanesEric Van Cutsem
Nature Clinical Practice. Gastroenterology & Hepatology|November 3, 2005
Can the addition of bevacizumab to IFL chemotherapy improve outcome in colorectal cancer?Eric Van Cutsem
European Journal of Oncology Nursing : the Official Journal of European Oncology Nursing Society|January 27, 2006
The causes and consequences of cancer-associated malnutritionEric Van Cutsem, Jann Arends
Lancet (London, England)|May 7, 2013
Regorafenib for metastatic colorectal cancer - Authors' replyEric Van Cutsem, Axel Grothey
JAMA|December 8, 2005
Progress in the adjuvant treatment of colon cancer: has it influenced clinical practice?Eric Van Cutsem, Frederico Costa
Pageof 50

Showing results (1-10 of 499) with videos related to

Sort By:
Pageof 50
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 20, 2006
Progress with biological agents in metastatic colorectal cancer leads to many challengesEric Van Cutsem
Clinical Advances in Hematology & Oncology : H&O|November 6, 2007
Integration of the anti-EGFR agent panitumumab into clinical practice in metastatic colorectal cancerEric Van Cutsem
Clinical Colorectal Cancer|December 6, 2007
Optimizing administration of epidermal growth factor receptor-targeted agents in the treatment of colorectal cancerEric Van Cutsem
Future Oncology (London, England)|November 26, 2025
Trastuzumab deruxtecan in HER2-positive stomach or gastroesophageal junction cancer: a plain language summary of the DESTINY-Gastric02 studyEric Van Cutsem
The Oncologist|October 13, 2006
Challenges in the use of epidermal growth factor receptor inhibitors in colorectal cancerEric Van Cutsem
The Oncologist|May 27, 2004
The treatment of advanced gastric cancer: new findings on the activity of the taxanesEric Van Cutsem
Nature Clinical Practice. Gastroenterology & Hepatology|November 3, 2005
Can the addition of bevacizumab to IFL chemotherapy improve outcome in colorectal cancer?Eric Van Cutsem
European Journal of Oncology Nursing : the Official Journal of European Oncology Nursing Society|January 27, 2006
The causes and consequences of cancer-associated malnutritionEric Van Cutsem, Jann Arends
Lancet (London, England)|May 7, 2013
Regorafenib for metastatic colorectal cancer - Authors' replyEric Van Cutsem, Axel Grothey
JAMA|December 8, 2005
Progress in the adjuvant treatment of colon cancer: has it influenced clinical practice?Eric Van Cutsem, Frederico Costa
Pageof 50